acquisition is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Eucalyptus, the most common co-covered peer. They are less corroborated than the beat average, carrying 2 original sources each against 2.4 for the same window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about GLP-1s
acquisition is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Eucalyptus, the most common co-covered peer. They are less corroborated than the beat average, carrying 2 original sources each against 2.4 for the same window. Their average consequence score of 7 runs above the beat's 6.5 for that window. We currently track 1 Startup story that mention GLP-1s, all published on February 24, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 32 Startup stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering GLP-1s. Shared-story counts are live from our verified record — not editorial picks.
US telehealth giant Hims & Hers has acquired Sydney-based startup Eucalyptus in a landmark $1.6 billion deal. The acquisition, fueled by a $637 million revenue run-rate and the global GLP-1 weight loss boom, has created over 100 overnight millionaires among the Australian firm's staff.
GLP-1s is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.